Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas.

Document Type : Original Article

Authors

1 Department of gynecology and obstetrics, Beni-Suef University, Egypt

2 Public Health Department, Faculty of Medicine, Beni-Suef University

3 Department of gynecology and obstetrics, Suez Canal University

Abstract

Background: Uterine fibroids are the most common tumor in women of reproductive age. By the time they are 50-years-old around 80% of women will have developed one. Of these, around half will experience symptoms which will impact negatively on their quality of life. Hysterectomy is the traditional treatment for women with symptomatic fibroids. For women who do not wish to undergo a hysterectomy, two invasive treatments are commonly available: myomectomy or uterine artery embolization (UAE). Aim and objectives: The present study has been done to compare quality of life after hysterectomy or myomectomy as treatment of fibroid. Methods: Women with symptomatic fibroids diagnosed by ultrasound were randomized to myomectomy or hysterectomy. Endpoints at 1 year were QoL measured by a validated questionnaire. Results: A statistically significant lower mean score was reported in the summary score (47.85±20.587 vs 53.35±27.548; P <0.001). The symptom severity score was higher among women planning hysterectomy compared with those planning myomectomy (62.85±26.547 vs 49.89±26.854), indicating worse symptoms among those scheduled for hysterectomy. Based on the EuroQoL 5-Dimension Health Questionnaire VAS, hysterectomy patients reported a lower quality of life compared with those planning to undergo myomectomy (68.26±21.424 vs 74.37±17.847; P<0.001, respectively). Conclusion: Hysterectomy and myomectomy substantially improved HRQOL at short-term follow-up (24 months), and there were small but statistically significant differences favoring hysterectomy in the Uterine Fibroid Symptom Quality of Life–specific subscales (concern, activity, and self-consciousness) and overall symptom severity

Keywords

Main Subjects

References

  1. Borah, B.J., Nicholson, W.K., Bradley, L., and Stewart, E.A. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013; 209: 319–321.
  2. Brüggmann D, Louwen F, Braun T et al. The uterine fibroid/myoma tumour: analysis of the global research architecture using density-equalizing mapping. Reproductive biomedicine online. 2018; 36(2), 227-238.
  3. Carroll BJ, Pinto DS and Sanina C. Chronic Venous Disorders. Endovascular Interventions. 2018; 251-265.
  4. Donnez J & Dolmans MM. Uterine fibroid management: from the present to the future. Human Reproduction Update. 2016; 22(6), 665-686.
  5. Edwards RD, Moss JG, Lumsden MA, et al.; Committee of the Randomized Trial of Embolization versus Surgical Treatment for Fibroids. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 2007; 356:360-370.
  6. McPherson K, Manyonda I, Lumsden MA et al. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial. Trials. 2014; 15(1), 468.
  7. Liu M, Cheng Z, Zhu Y et al. Prospective comparison of laparoscopic uterine artery occlusion plus myomectomy with classic intrafascial supracervical hysterectomy for symptomatic fibroid treatment: differences in post-operative quality-of-life measures. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2011; 155(1), 79-84.
  8. Nicholson WK, Wegienka G, Zhang S et al. Short-Term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas. Obstetrics & Gynecology. 2019; 134(2), 261-269.
  9. Manyonda IT, Bratby M, Horst JS et al. Uterine artery embolization versus myomectomy: impact on quality of life—results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. Cardiovascular and interventional radiology. 2012; 35(3), 530-536.
  10. Fortin C, Flyckt R & Falcone T. Alternatives to hysterectomy: the burden of fibroids and the quality of life. Best Practice & Research Clinical Obstetrics & Gynaecology. 2018; 46, 31-42.
  11. Hartmann KE, Fonnesbeck C, Surawicz T et al. Summary of Existing Systematic Reviews. In Management of Uterine Fibroids [Internet]. Agency for Healthcare Research and Quality (US); 2017.
  12. Nicholson WK, Ganesa Wegienka, Shuaiqi Zhang, Kedra Wallace, Elizabeth Stewart, Shannon Laughlin-Tommaso, Laine Thomas, Vanessa L. Jacoby, Erica E. Marsh, Lauren Wise, Bijan J. Borah, James Spies, Sateria Venable, Raymond M. Anchan, G. Larry Maxwell, Michael Diamond, Barbara Lytle, and Evan R. Myers, Short-term Health-Related Quality of Life After Hysterectomy Compared With Myomectomy for Symptomatic Leiomyomas; Volume 74, Number 11 obstetrical and gynecological survey Copyright © 2019 Wolters Kluwer Health.
  13. Rock JA. Quality-of-life assessment in gynecologic surgery. J Reprod Med 2001; 46:515-519.
  14. Rowe MK, Kanouse DE, Mittman BS, Bernstein SJ. Quality of life among women undergoing hysterectomies. Obstet Gynecol 1999; 93:915-921
  15. Wallace, K., Zhang, S., Thomas, L., Stewart, E.A., Nicholson, W.K., Wegienka, G.R. et al. Comparative effectiveness of hysterectomy versus myomectomy on 1-year health-related quality of life in women with uterine fibroids. Fertil Steril. 2020; 113: 618–626
  16. Llarena N and Falcone T, Does hysterectomy result in better quality of life than myomectomy?, DOI: https://doi.org/10.1016/j.fertnstert.2019.11.020

 

 

Egyptian Journal of Medical Research
Volume 3, Issue 3
July 2022
Pages 155-166

Files

Share

How to cite

Statistics